AR and neoplasm: Additionally, PD-L1 overexpression was more prevalent in patients with advanced tumor stage, high GS, and positive surgical margin and positive AR status, which suggested the potential of a combined strategy featuring anti-PD-L1 immunotherapy and ADT or radiotherapy in consideration in certain situations.